Building honest dialogue with patient advocatesHow can the industry listen to patients in a way that puts the person behind the disease first? Share XBuilding honest dialogue with patient advocateshttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/building-honest-dialogue-with-patient-advocates/
How can the pharma industry help build a greener NHS?NHS England has set its sights on becoming the world’s first net zero health system by 2045 – Share XHow can the pharma industry help build a greener NHS?https://pharmaphorum.com/views-and-analysis/how-can-the-pharma-industry-help-build-a-greener-nhs/
Turning words into actions with patient engagementBoehringer Ingelheim’s Carinne Brouillon tells us how the company co-created its recent Global Patient Partnership Summit with patients Share XTurning words into actions with patient engagementhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/turning-words-into-actions-with-patient-engagement-boehringer-ingelheim/
Supporting and empowering carers to make their voices heardThere are an estimated nine million carers in the UK, and their contributions to society, individually and as Share XSupporting and empowering carers to make their voices heardhttps://pharmaphorum.com/views-and-analysis/supporting-empowering-carers-voices/
Pandemic paves way for innovative hybrid healthcareWhile the heroic abilities of the NHS have been on display throughout the COVID-19 pandemic, the last year Share XPandemic paves way for innovative hybrid healthcarehttps://pharmaphorum.com/views-and-analysis/playing-catch-up-the-evolution-of-pharma-marketing/
Transforming pharma R&D with a scientist-centric approach to AI & automationAs biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new Share XTransforming pharma R&D with a scientist-centric approach to AI & automationhttps://pharmaphorum.com/views-and-analysis/transforming-pharma-rd-with-a-scientist-centric-approach-to-ai-automation/
A roadmap for adopting New ScienceThe pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community Share XA roadmap for adopting New Sciencehttps://pharmaphorum.com/market-access-2/a-roadmap-for-adopting-new-science/
How the patient voice is becoming vital for drug approvalRebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed Share XHow the patient voice is becoming vital for drug approvalhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/patient-voice-drug-approvals-lipodystrophy/
What’s affordable anyway? The future of NHS drug spendingThe single biggest monetary difference that can be made to the successor to the UK’s 2019 Voluntary Scheme Share XWhat’s affordable anyway? The future of NHS drug spendinghttps://pharmaphorum.com/views-and-analysis/vpas-future-nhs-drug-spending/
